Active Ingredient: LISINOPRIL
Proprietary Name: QBRELIS
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: 1MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208401
Product Number: 001
Approval Date: Jul 29, 2016
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
